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Abstract
The dopamine receptor D4 (DRD4) is one of the most studied candidate genes for Attention-Deficit/Hyperactivity
Disorder (ADHD). An excess of rare variants and non-synonymous mutations in the VNTR region of 7R allele in
ADHD subjects was observed in previous studies with clinical samples. We hypothesize that genetic heterogeneity in
the VNTR is an important factor in the pathophysiology of ADHD. The subjects included in the present study are
members of the 1993 Pelotas Birth Cohort Study (N=5,249). We conducted an association study with the 4,101
subjects who had DNA samples collected. The hyperactivity-inattention scores were assessed through the parent
version of the Strengths and Difficulties Questionnaire at 11 and 15 years of age. The contribution of allele’s length
and rare variants to high hyperactivity/inattention scores predisposition was evaluated by multivariate logistic
regression. No effect of allele length was observed on high scores of hyperactivity-inattention. By contrast, when
resequencing/haplotyping was conducted in a subsample, all 7R rare variants as well as non-synonymous 7R rare
variants were associated with high hyperactivity/inattention scores (OR=2.561; P=0.024 and OR=3.216; P=0.008
respectively). A trend for association was observed with 4R rare variants. New coding mutations covered 10 novel
motifs and many of them are previously unreported deletions leading to different stop codons. Our findings suggest a
contribution of DRD4 7R rare variants to high hyperactivity-inattention scores in a population-based sample from a
large birth cohort. These findings provide further evidence for an effect of DRD4 7R rare variants and allelic
heterogeneity in ADHD genetic susceptibility.
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Introduction
Attention-deficit/hyperactivity disorder (ADHD) is
characterized by impairing symptoms of inattention and/or
hyperactivity and impulsivity [1]. This disorder has a heritability
of approximately 76% [2], affecting about 5% of school-age
children. It is a precursor of behavioral problems in
adolescence and adulthood [3]. Among the dopamine-related
genes investigated to date, the dopamine receptor D4 (DRD4)
gene has been widely studied and it is the candidate gene with
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the strongest association with ADHD in different meta-analysis
studies [4]. The most investigated polymorphism is a 48pb
VNTR in its third exon. The alleles vary from two to eleven fold
repeat (2R-11R), and the most prevalent are the 4R (65.1%),
7R(19.2%) and 2R(8.8%) [5]. Despite the evidences that 7R
allele might be a susceptibility allele for ADHD, different groups
have reported mixed results [4].
The VNTR region encodes a portion of the third cytoplasmic
loop of Dopamine D4 Receptor which is considered an
intrinsically disordered region of proteins. These regions lack a
stable 3-D unique conformation and provide large interaction
surface, conformational flexibility and exposure of short linear
motifs, mediating the interaction with several partners [6].
Some properties described as important for signal transduction
and proper protein functionality are usually associated to
disordered regions, such as degradation (PEST) motifs, post-
translational modifications and linear interaction motifs [7-9].
Dopamine D4 Receptor presents several SH3 motifs
recognized in its third cytoplasmic loop [10]. Although their
biological function within DRD4-VNTR has not been fully
elucidated, this kind of domain-binding motif is widely
described as important in cell–cell communication and signal
transduction [11].
In addition to repeat number variation, rare variants inside
the VNTR region were also described [12-16]. The combination
of specific mutations results in different motifs (repeats) that
are identified by numbers [12]. The haplotypes are composed
by a specific combination of repeats (see 12-15 for more
details, and Figure S1). 2R (1-4), 4R (1-2-3-4) and 7R
(1-2-6-5-2-5-4) are the most frequent haplotypes on worldwide
populations [12-15]. The other haplotypes are considered rare.
A growing number of evidence suggests that rare haplotypes
are an important risk factor to develop ADHD, but the literature
addressing this topic is extremely scarce. Higher frequency of
rare variants in ADHD probands compared to both control
individuals [13] and children with autism [14] was reported.
Recently, it has been documented that ADHD Brazilian
subjects from a clinical sample presented an excess of rare
variants as well as non-synonymous mutations compared to
controls. It is noteworthy that these differences were restricted
to 7R allele [16].
General-population studies have important advantages over
case–control studies [17,18]. When the main objective is to
explore rare variants variability and their contribution to
complex diseases, this design represents a unique opportunity
due to the large sample size. Another important aspect is that
clinical cases do not represent the full spectrum of cases found
in the general population for the majority of disease, especially
for mental disorders [19]. Considering that, genetic findings on
ADHD in clinical samples might not be representative of the
general populations since ADHD represents only the most
severe part of the phenotype and it might be determined by
different genetic mechanisms than other portions of the
inattentive and hyperactive/impulsive trait in the population
[20]. Thus, it is of interest to assess the role of the DRD4 allele
length variants as well as rare variants in ADHD etiology in the
general population.
The aims of the current study are to investigate the
association of DRD4 VNTR length and rare variants with an
epidemiological measure of inattention and hyperactivity/
impulsivity symptoms in a Brazilian birth cohort study. We also
explore the impact of non-synonymous rare mutations in the
ADHD etiology.
Results
Ten different DRD4 VNTR alleles with 2 to 11 tandem
repeats were present in this study. The 4/4R was the most
observed genotype in both hyperactivity/inattention low-score
and high-score groups, followed by 4/7R genotype. The
genotypic frequencies observed in the total population as well
as in the low-score and high-score groups are shown in Table
S1. To evaluate the effect of 7R allele in this sample, DRD4
VNTR genotypes were grouped into two categories: with and
without 7-repeat allele. A logistic regression adjusted for the
effect of gender and ethnicity was performed. Genotypes
containing the 7R allele were not associated with high
hyperactivity/inattention scores (Table 1).When an allelic model
was tested, again no association was observed with high
hyperactivity/inattention scores (Table S2).
As rare variants inside the VNTR are hypothesized as being
a possible confounder for usual DRD4 VNTR and ADHD
association studies, all 2R(n=31) and 7R(n=175) and many
randomly selected 4R(n=521) homozygous had the VNTR
region sequenced, comprising a sample size of 727 individuals.
Considering the 1,454 sequenced alleles, we covered 30
different haplotypes: two at 2R allele, 15 at 4R and 13 at 7R
alleles (Table 2, Figure S1). As expected, the most frequent
haplotypes found in our general population sample were 2R
(1-4), 4R (1-2-3-4) and 7R (1-2-6-5-2-5-4). A number of new
coding SNPs covered 10 novel motifs (repeats from 39 to 48;
Figure 1). Six novel haplotypes were found in 4R allele
category and six in 7R. Among new motifs, we identified many
unreported deletions. Two of them are1bp deletions at 7R
allele. The first is a modification of a repeat previously identified
as number 6 [12] where a deletion of a cytosine is observed at
the 21st base of the VNTR motif. This repeat was called 42. The
other is a modification of motif number 1 where a deletion of a
cytosine located at position 20 of the motif is found (repeat 43).
The alignment of deleted motifs as well as their chromatograms
can be seen on Figure 1, Figure 2 and Figure S1. These
deletions lead to a frameshift with the occurrence of a
premature stop codon at the position 393(M393X) instead of
the position 468 in the protein. The other alteration comprises a
26bp deletion at the 4R allele (Figure 2). This deletion leads to
a frameshift in which the stop codon UGA at position 420 is
substituted by the codon for arginine. Translation of the protein
thus continues until a stop codon encountered at codon 440,
leading to a 20-residue-long C-terminal tail. In both cases, the
two last transmembrane domains of D4 receptor would be
drastically altered by incorporation of several disordered
instead of hydrophobic residues, as shown by transmembrane
topology prediction (Figure 2).
To evaluate the impact of rare variants in hyperactivity/
inattentions scores, two models of multivariate logistic
DRD4 Rare Variants in ADHD
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regressions were performed based on different strategies of
pooling rare variants. The frequency of rare variants in case
and control group is described in Table 2.
As 7R rare variants are suggested to be associated to
ADHD, rare variants were classified in specific 4R and 7R and
included in the regression analysis as independent variables
(first logistic regression model). This analysis revealed that
individuals carrying at least one 7R rare haplotype were at a
significantly increased risk for developing high hyperactivity/
inattention scores compared with those homozygous for most
Table 1. Frequency of DRD4-VNTR genotypes regarding
presence or absence of 7R allele and rare variants and
respective estimated odds ratios (OR) for high hyperactivity
and inattention scores.
Model Genotype
Low-score
group n
(%)A
High-
score
group n
(%)A OR (95% CI)
P-
valueD
VNTR allele
length 7R carriers
1,047
(35.8%)
122
(36.0%)
1.029
(0.812-1.302)B 0.815
 Others 1,879(64.2%)
217
(64%) 1 --
Sequences -
Model 1
(Synonymous
and non-
synonymous
included)
Presence of
at least 1
copy of 4R
rare variant
77
(15.0%)
14
(21.0%)
1.790
(0.901-3.557)C 0.096
 
Presence of
at least 1
copy of 7R
rare variant
38
(7.4%)
9
(13.4%)
2.561
(1.133-5.790)C 0.024
 Commonvariants
398
(77.6%)
44
(65.6%) 1 --
Sequences -
Model 2 (Only
non-
synonymous
included)
Presence of
at least 1
copy of 4R
rare protein
variant
61
(11.9%)
10
(14.9%)
1.593
(0.740-3.428)C 0.234
 
Presence of
at least 1
copy of 7R
rare protein
variant
30
(5.8%)
8
(11.9%)
3.216
(1.348-7.671)C 0.008
 Commonvariants
422
(82.3%)
49
(73.2%) 1 --
A The analysis considering VNTR allele length comprised a sample size of 3,265
subjects (2,926 in low-score group and 339 in high-score group) while the analysis
with the sequences comprised 580 subjects (513 in in low-score group and 67 in
high-score group);
B Logistic regression adjusted for gender and ethnicity;
C Logistic regression adjusted for gender, ethnicity and alcohol consumption during
pregnancy;
D Significance level at 0.05
doi: 10.1371/journal.pone.0085164.t001
common haplotypes (OR=2.561; P=0.024). A trend for
association was observed for 4R rare variants (Table 1).
As mutations that determine amino acid changes might be
deleterious and potentially disease causing, we investigated
the impact of non-synonymous substitution of rare variants in
hyperactivity/inattention symptoms. For this analysis individuals
Table 2. Haplotypes observed in total sample, in low-score
and high-score group sand their frequencies.
Haplotype per
Allele length
Population
sample
ALow-
score
group
BHigh-
score
group
Published
populational
data [12,16]
Published
ADHD
sample
[13,16]
2R Allele N=62 N=50 N=0 N= 55 N=23
1-4 61 (98.4%) 50(100%) 0 43 (78.2%) 23 (100%)
30-4 1 0 0 12 0
4R Allele N=1,042 N=738 N=96 N=292 N=225
1-2-3-4 912(87.5%)
655
(88.8%)
82
(85.4%) 281 (96.2%) 211 (93.4%)
1-2-13-4 34 22 5 3 2
1-2-14-4 32 20 4 3 3
1-8-3-4 27 17 2 1 2
1-2-5-4 14 11 0 1 4
1-2-12-4 3 2 1 2 0
1-2-6-4 2 2 0 0 2
1-26-3-4 1 1 0 0 1
1-17-3-4 1 0 0 1 0
1-2-14-47 4 2 0 0 0
1-2-48-4 1 0 0 0 0
1-46-13-4 6 3 2 0 0
45-2-3-4 2 1 0 0 0
44-2-3-4 2 1 0 0 0
Allele3.5R 1 1 0 0 0
7R Allele N=350 N=238 N=38 N=218 N=110
1-2-6-5-2-5-4 287(82.0%)
197
(82.8%)
28
(73.7%) 206 (94.5%) 94 (85.5%)
1-2-6-5-2-5-19 15 10 1 5 3
1-8-25-5-2-5-4 14 10 3 2 3
1-2-3-17-2-5-4 10 6 1 2 3
1-2-6-1-2-3-4 8 4 2 0 4
1-2-6-5-2-3-4 6 5 1 3 2
1-2-5-5-2-5-4 3 1 1 0 0
1-2-6-5-37-5-4 1 1 0 0 1
1-2-6-5-39-3-4 1 0 0 0 0
40-2-6-5-2-5-4 1 1 0 0 0
1-41-6-5-2-5-4 1 1 0 0 0
1-2-42-5-2-5-4 1 1 0 0 0
43-2-6-5-2-5-4 2 1 1 0 0
The Haplotypes 1-4 and 30-4 Encode the Same Protein, the Haplotypes 1-2-14-4
and 45-2-3-4 Encode the Same Protein as 1-2-3-4. The Haplotype 1-2-6-5-2-5-19
Encodes the Same Protein as 1-2-3-5-6-5-4
A SDQ hyperactivity-innatention≤7 at 11 and 15 years-old
B SDQ hyperactivity-innatention≥8 at 11 and 15 years-old
In bold are the novel haplotypes found.
doi: 10.1371/journal.pone.0085164.t002
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were classified as carrying or not 4R or 7R variants that have
at least one non-synonymous mutation. 4R rare haplotypes
containing missense variants presented a trend in ADHD risk.
On the other hand, carriers of 7R rare haplotypes containing
missense variants had a greater than three-fold increase in the
odds of developing higher hyperactivity/inattention scores as
compared to those homozygous for the common haplotype
(OR=3.216; P=0.008; Table 1).
Many functional properties related to protein disorder were
assessed in each haplotype. The results of potential alterations
due to mutations are shown in table 3 and Figure S2. As
expected, this region was predicted as to be highly disordered.
Although the estimated mean disorder indexes are high and
very similar for all haplotypes, many differences can be
observed if the mutations are individually analyzed (Figure S2).
Many of them confer disorder to order substitution on protein,
such as R>C, G>C, G>V and P>Q. When the phosphorylation
of serines, threonines and tyrosines were considered, the
alterations were more obvious. Many mutations created
potential phosphorylation sites in in two 7R (1-2-6-5-37-5-4)
(Serine 74) and (40-2-6-5-2-5-4) (Serine 9) haplotypes.
Regarding the potential sites for interaction and/or degradation
PEST motifs were predicted in the 4R(1-17-3-4),
7R(1-8-25-5-2-5-4) and 7R(1-2-6-5-37-5-4) haplotypes. The
most frequent haplotypes showed no potential sites for
phosphorylation or potential PEST motifs. Moreover, many
SH3 binding sites were described as disrupted in the following
haplotypes: 4R(1-17-3-4) (aa 22-28), 7R(1-2-3-17-2-5-4) (aa
61-67) and 7R(40-2-6-5-2-5-4) (aa 3-9, 6-12).
Discussion
We reported herein the unusual architecture of DRD4 gene
as well as an important association between high hyperactivity-
inattention scores and rare variants, especially in 7R allele. Our
analysis suggests that 7R rare variants might have a
contribution to the multifactorial inheritance of ADHD while 7R
length allele might not.
Our results are in agreement with previous findings [12-16].
We observed a high variability inside DRD4 VNTR in the
general population as reported elsewhere [12-15]. Also, a
higher variability in the DRD4-VNTR region was observed in
ADHD subjects when compared to controls [13] and to autistic
subjects [14]. It is important to emphasize that all published
results addressing this subject to date showed a consistent
association between DRD4 rare variants, especially inside 7R
allele, and ADHD [13,14,16].
An increasing body of evidence suggests that rare variants
may play a role in complex diseases, including
neuropsychiatric traits. To date the Genome Wide Association
(GWA) studies conducted on ADHD samples were not able to
find any common variants significantly associated with the
disorder. Although the small sample size involving these
studies is pointed as a possible limitation to find a significant
association at genomic level, “synthetic” signals of association
on GWA in other case-control studies are reported [21]. Then,
the common-disease-rare-variant (CDRV) hypothesis is an
attractive framework to understand the susceptibility of the
disorder. This hypothesis proposes that the sum of the effects
of a series of low frequency variants, each conferring a
Figure 1.  Nucleotide and amino acid sequences of the novel VNTR motifs.  The nucleotide and corresponding amino acid
(bold) sequences of 10 novel DRD4 exon3 48-bp repeat motifs are shown (repeats 39-48). * indicates 1bp deletion motifs.
doi: 10.1371/journal.pone.0085164.g001
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moderate but readily detectable increase in relative risk,
compose an important proportion of the overall genetic risk for
common diseases etiology [22]. Recent findings have drawn
attention to the involvement of rare structural variants in the
pathophysiology of ADHD [23]. Point mutations inside DRD4
appear to be another important example of this phenomenon.
Our analysis suggests that rare variants may make a
contribution to the multifactorial inheritance of common
diseases. Thus, even though individual rare variants may not
contribute much to the overall inherited tendency of a disease,
their discovery is likely to be important for understanding
disease etiology. Another important aspect of this study is its
focus on the identification of multiple rare variations, since
individuals with ADHD might frequently possess any of them.
This suggests that all the variations contributing to the pool of
variations that were greater in frequency among the individuals
with the disease phenotype might perturb D4 receptor activity.
Many studies already addressed the plausibility of studying
the impact of mutations in disordered regions [24,25]. The main
hypothesis is that altering the disorder status in proteins could
affect many important biological processes [25]. In this study
we observed that many mutations are able to perturb some
disorder-related properties. Differences in disorder profile,
PEST motifs recognition, additional phosphorylation sites and
disruption of binding sites could affect D4 receptor functionality.
Among the possible impaired functions there are reduction of
loop flexibility, facilitated recognition for internalization and
degradation, unusual desensitization, homo-heterodimerization
Figure 2.  Characterization of DRD4 novel deletions.  (A) PCR analysis of 3.5 allele. Lane 1: DNA 50bp marker, Lane 2:
homozygote for 2 repeats; Lane 3 homozygote for 3 repeats; Lane 4: homozygote for 4 repeats; Lane 5: heterozygote for 3 and 4
repeats; Lane 6: heterozygote for 3.5 and 4 repeats. PCR products were run on a 3.5% agarose gel. A heteroduplex band is seen
for heterozygotes in lanes 5 and 6. (B) The allele 3.5R alignment. The 3.5R refers to an allele with a length between 3 and 4
repeats. Sequencing of this size allele revealed a deletion of 26bp sequence (11bp immediate 5’ downstream sequence of the
VNTR and 15bp inside the first repeat of VNTR) of the most common 4R haplotype. (C) Sequence chromatogram of DRD4-7R
nucleotide deletions(arrow) at VNTR positions117 (del117C, above) and 20 (del20C, below). (D) Topology prediction of proteins
encoded by VNTR with (below) and without (above) deletions. Schematic diagram of the transmembrane region (yellow). The
deletions exclude the prediction of the two last transmembrane domains.
doi: 10.1371/journal.pone.0085164.g002
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disparities, and disruption of usual interactions. Further
functional studies as well as studies evaluating DRD4
variability in other psychiatric disorders are needed to better
understand the role of these mutations in disease etiology.
This is the first study showing potential null alleles due to
deletions inside the VNTR. In humans, only one homozygous
for the null allele was reported [26]. Although the subject did
not present ADHD or other psychiatric disorder, many
symptoms possibly related to the absence of DRD4 protein
Table 3. Functional predictions related to disordered
regions for observed haplotypes.
Haplotype per
Allele length
ADisorder
Index
(Mean)
PEST motif
EpestFind
BPhosphorylation
(Residue)
BSH3 sites
ELM
(Position of
missing
sites)
2R Allele     
1-4 0.7411 Absence No 5
30-4 0.7411 Absence No 5
4R Allele     
1-2-3-4 0.851 Absence No 13
1-2-13-4 0.848 Absence No 13
1-2-14-4 0.851 Absence No 13
1-8-3-4 0.810 Absence No 13
1-2-5-4 0.857 Absence No 13
1-2-12-4 0.848 Absence No 13
1-2-6-4 0.856 Absence No 13
1-26-3-4 0.842 Absence No 13
1-17-3-4 0.858 Presence No 12 (22-28)
1-2-14-47 0.834 Absence No 13
1-2-48-4 0.856 Absence No 13
1-46-13-4 0.848 Absence No 13
45-2-3-4 0.851 Absence No 13
44-2-3-4 0.819 Absence No 13
Allele3.5R -- -- -- --
7R Allele     
1-2-6-5-2-5-4 0.906 Absence No 25
1-2-6-5-2-5-19 0.906 Absence No 25
1-8-25-5-2-5-4 0.884 Presence No 25
1-2-3-17-2-5-4 0.907 Absence No 24 (61-67)
1-2-6-1-2-3-4 0.893 Absence No 25
1-2-6-5-2-3-4 0.903 Absence No 25
1-2-5-5-2-5-4 0.907 Absence No 25
1-2-6-5-37-5-4 0.912 Presence Yes (Ser74) 25
1-2-6-5-39-3-4 0.903 Absence No 25
40-2-6-5-2-5-4 0.904 Absence Yes (Ser9) 23 (3-9;6-12)
1-41-6-5-2-5-4 0.874 Absence No 25
1-2-42-5-2-5-4 -- -- -- --
43-2-6-5-2-5-4 -- -- -- --
A The graphics showing individual disorder index for each amino acid are shown in
Figure S2.
B The positions of residues are related to VNTR peptide sequence showed in
Figure S2
doi: 10.1371/journal.pone.0085164.t003
were observed, such as somatic ailments, obesity and
disturbances of the autonomic nervous system [26]. Out of four
subjects containing deletions presented here, only one had
extreme phenotypes. However, all subjects are heterozygotes.
Further careful phenotype assessment of subjects carrying null
alleles is needed to better clarify the role of the DRD4 gene in
normal and pathologic development.
Our results must be interpreted in the context of some
limitations. Although the hyperactivity/Inattention subscale of
the SDQ shows high diagnostic performance for ADHD, the
use of this epidemiological instrument might have created
biases in our phenotypic definition. However, it is important to
note that our analyses were based on individuals who were
classified in the same group – low or high score groups – in
both assessments. So, we are confident that we selected those
individuals in the population with deviant and stable inattentive/
hyperactive profile. Second, no genomic control was
performed. Therefore our findings might have been biased by
hidden genetic heterogeneity present in our specific sample of
the southern Brazilian population. However, our case and
control groups contain a similar ethnic distribution and the
analysis was adjusted for ethnicity. Moreover, it is important to
note that recent studies using different sets of informative
markers did not show heterogeneity across main Brazilian
populations [27] or significant population structure in southern
Brazilians [28]. Finally, since the 10 novel motifs found could
be artifacts, we re-sequenced all samples in which they were
observed through different PCR products to confirm mutations.
In conclusion, DRD4 7R rare variants are associated with
hyperactivity and inattention at the general population level
confirming previous studies on ADHD probands. These results
indicate that the DRD4 7R rare variants could play an important
role in ADHD genetic susceptibility. In silico analysis of putative
effect of these mutations on receptor function suggests that
they could have an impact on receptor signaling, degradation,
internalization and desensitization. In addition, we document
that taking in consideration the sequence of DRD4 VNTR is
very important to estimate the contribution of this dopaminergic
receptor to the pathophysiology of ADHD.
Material and Methods
Ethics Statement
The project was approved by the Institutional Review Board
of the School of Medicine, Federal University in Pelotas
(UFPel). Parents or guardians signed an informed consent
form authorizing their own participation and that of the children
in the study.
Subjects
Subjects included in the present study were members of the
1993 Pelotas Birth Cohort Study [29,30], a birth cohort carried
out in the municipality of Pelotas, Southern Brazil in 1993. This
article draws on data collected at the perinatal visit and the 11-
year and 15-year follow-up visits. From all live births in the city
of Pelotas in Brazil (N=5,249), 87.5% and 85.7% of them were
respectively re-assessed at 11 and 15 years of age (for more
details, see Figure S3).
DRD4 Rare Variants in ADHD
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Phenotypic Assessments
To evaluate attention and hyperactivity/impulsive problems,
mothers or guardians answered the Strengths and Difficulties
Questionnaire (SDQ) [31]. The SDQ is one of the most
commonly used and validated instruments to assess child
mental health in epidemiological samples [32,33]. It comprises
25 questions and allows computation of raw scores for five
sub-scales with five questions each: emotional symptoms,
conduct problems, hyperactivity (and inattention) symptoms,
problems with peer relations, and pro-social behavior
problems. Our outcome variable was the sub-scale of attention/
hyperactivity problems from the parents’ version of SDQ [34].
DNA Collection and Genotyping
Out of the total sample size, 4,101 subjects had the DNA
collected and were genotyped for the VNTR polymorphism.
Saliva DNA of the adolescents was isolated using the Oragene
DNA kit (DNA GenotekInc Ontario, Canada) according to the
manufacturer’s instructions. For amplification of the VNTR in
DRD4 exon III, D4-3 and D4-42 primers described previously
were used [15]. PCRs were conducted in 25-μl volumes
containing 40ng of genomic DNA, 5% DMSO, 2mM MgCl2,
200μM dATP, dCTP, dTTP, 100μM dGTP, 100 μM 7-deaza-
dGTP, 1.2μM of each primer, 1× PCR buffer (Promega), and 1
unit of GoTaqHotStart DNA polymerase (Promega).
Amplification was performed by using Veriti™ Thermal Cyclers
(Applied Biosystems). A 2-min, 94°Cinitial denaturation was
used followed by 35 cycles of 95°C for 30 sec, 62°C for 30 sec
and 72°C for 40 sec. The final step was annealing of 74°C for 4
min. Out of 4,101 amplified subjects, all 2R and 7R and
random 521 4R homozygous were selected to have the VNTR
region sequenced, comprising a sample size of 727 individuals.
One 2R and seven 7R homozygous subjects failed to have
their DRD4 VNTR sequenced after three times and were
excluded from subsequent analysis. The PCR products
consisted in fragments of 379bp for 2R allele, 475bp for 4R
allele and 619bp for 7R allele. These amplicons were purified
by enzymatic treatment before sequencing as reported [12].
For the individual carrying the 3.5R allele, the two allelic PCR
products (3.5R and 4R alleles) were isolated and then both
alleles were sequenced. The sequencing procedure and
primers used were previously reported [16]. When new
mutations were observed or when sequences were dubious,
the samples were resequenced through independent PCR
products. DNA sequences of the novel DRD4 haplotypes
reported in this paper have been submitted to GenBank
(Accession numbersJQ064942-JQ064953).
Sequences and Bioinformatic Analysis
Sequence analyses were accomplished using CodonCode
Aligner v3.0.1 software (Codon Code Corporation, Dedham,
MA). Haplotypes were estimated using a Bayesian method
implemented in PHASE2.1 software [35]. The haplotypes were
derived according to the motifs and point mutations as
described previously [12]. Transmembrane topology prediction
was provided by MEMSAT3algorithm [36] available via the
PSIPRED server (http://bioinf.cs.ucl.ac.uk/psipred/). To access
the possible effect of mutations in the protein, we analyzed the
sequences considering different parameters. We estimated the
mean disorder index for each predicted peptide using PONDR®
VT-LX predictor (www.pondr.com) [37]. PEST motif is a
classical protein degradation targeting signal enriched in
proline (P), glutamic acid (E), serine (S) and threonine (T) and
confers rapid instability to proteins. Presence or absence of this
motif was evaluated through ePESTfind server (http://
emboss.bioinformatics.nl/cgi-bin/emboss/epestfind) [7].
Presence of unusual phospohorylation sites using NetPhos 2.0
server (http://www.cbs.dtu.dk/services/NetPhos/) [38], and
prediction of SH3 binding sites using ELM server (http://
elm.eu.org/) [39]. Access to PONDR® was provided by
Molecular Kinetics. VL-XT is copyright©1999 by the WSU
Research Foundation, all rights reserved. PONDR® is
copyright©2004 by Molecular Kinetics, all rights reserved.
Statistical Analysis
Our dependent variable is defined as a SDQ attention and
hyperactivity score ≥ 8 in both assessments at 11 and 15 years
of age. The rationale for this method of dichotomizing high vs.
low hyperactivity/inattention scores in the current sample is
described elsewhere [40]. Briefly, in order to assure that we
were dealing with a clear deviant and stable phenotype,
sample dichotomization in high (score > 8) and low (score < 7)
hyperactivity/inattention scores in the SDQ hyperactivity-
inattention subscale at both 11 and 15 years old was
established according to previous analysis of ADHD in this
sample. This threshold showed adequate diagnostic
performance for ADHD [40]. All phenotype definitions were
done a priori of any analyses.
A binary variable indicating whether subjects had “high
hyperactivity/inattention score” was used as the dependent
variable in logistic regression analyses. The first analysis
focused on the association between the genotypes with DRD4
7R allele (risk allele), and presence of high hyperactivity/
inattention score. Out of the initial sample size (4,101 subjects),
3,265 subjects were included in the analysis. Following the cut-
off criteria mentioned above, those subjects that presented
discordant hyperactivity/inattention scores at 11 and 15 were
excluded from the analysis (Figure S3). Subsequent analyses
included the subsample selected for VNTR sequencing (out of
the 727 sequenced samples, 580 individuals had concordant
hyperactivity/inattention scores at both assessments and, thus,
were included in the analyses). To exclude the effect of
genotype in the subsample, a multivariate logistic regression
considering the allele length as main effect adjusted for gender
and ethnicity was performed. As no association was observed
(Table S3), the participants were grouped according to genetic
variation in the DRD4-VNTR sequence following two strategies:
1) carriers and non-carriers of 4R or 7R rare variants and 2)
carriers and non-carriers of 4R or 7R rare variants with
missense mutations. Thus, two independent models were
constructed to assess potential odds ratio for high scores of
attention and hyperactivity in carriers of 4R or 7R rare variants
and carriers of 4R or 7R rare variants with non-synonymous
mutations with 95% confidence intervals (95% CI) using
multivariate logistic regression with adjustment for potential
confounders. These groups were compared to common variant
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carriers. Potential confounders (gender, alcohol consumption
during pregnancy and ethnicity) comprise a priori selected
variables based on conceptual analyses of the literature and on
a statistical definition (association with the main factor and with
the outcome at P< 0.10). Statistical significance was defined as
a two-tailed P-value < 0.05. Statistical analysis was performed
using PASW Statistics 18, Release Version18.0.0 (SPSS, Inc.,
2009,Chicago, IL, USA, www.spss.com).
In this study, the term ‘‘motif’’ refers to a variant sequence of
the VNTR 48bp repeat unit. A haplotype means a specific motif
composition, and allele refers to a specific length variant.
Haplotype nomenclature and the criteria to define rare
haplotypes were those previously described [12-14].
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